SLV 332

Drug Profile

SLV 332

Alternative Names: Neurokinin 2 antagonist - Solvay; NK-2 antagonist - Solvay; SLV-332

Latest Information Update: 11 Jul 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator ArQule
  • Class Irritable bowel syndrome therapies
  • Mechanism of Action Neurokinin 2 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Irritable bowel syndrome

Most Recent Events

  • 11 Jul 2007 Discontinued - Preclinical for Irritable bowel syndrome in Europe (unspecified route)
  • 29 Sep 2006 Data presented at the 232nd American Chemical Society National Meeting (232nd-ASC-2006) have been added to the Digestive System Disorders pharmacodynamics section
  • 01 Sep 2005 SLV 332 is still in active development - BIO-2005 Annual International Convention (BIO-2005)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top